CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zapka, J. G.
Right arrow Articles by Manos, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zapka, J. G.
Right arrow Articles by Manos, M. M.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 4-13, January 2003
© 2003 American Association for Cancer Research

Commentary

A Framework for Improving the Quality of Cancer Care

The Case of Breast and Cervical Cancer Screening1

Jane G. Zapka2, Stephen H. Taplin, Leif I. Solberg and M. Michele Manos

University of Massachusetts Medical School, Division of Preventive and Behavioral Medicine, Worcester, Massachusetts 01655 [J. G. Z.]; Group Health Cooperative, Center for Health Studies, Seattle, Washington 98101 [S. H. T.]; Health Partners Research Foundation, Minneapolis, Minnesota 55440 [L. I. S.]; and Kaiser Permanente Northern California, Oakland, California 94611 [M. M. M.]

This commentary presents a conceptual framework, Quality in the Continuum of Cancer Care (QCCC), for quality improvement studies and research. Data sources include review of relevant literature (cancer care, quality improvement, organizational behavior, health services evaluation, and research). The Detecting Early Tumors Enables Cancer Therapy (DETECT) project is used to apply the QCCC model to evaluate the quality of secondary prevention. Cancer care includes risk assessment, primary prevention, screening, detection, diagnosis, treatment, recurrence surveillance, and end-of-life care. The QCCC model represents a systematic approach for assessing factors that influence types of cancer care and the transitions between them, the factors at several levels (community, plan and practice setting) that potentially impact access and quality, and the strategies groups and organizations can consider to reduce potential failures. Focusing on the steps and transitions in care where failures can occur can facilitate more organized systems and medical practices that improve care, establish meaningful measures of quality that promote improved outcomes, and enhance interdisciplinary research.




This article has been cited by other articles:


Home page
 AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
J. G. Zapka
Prevention Research and Reality: Narrowing the Quality Chasm
American Journal of Lifestyle Medicine, June 1, 2008; 2(3): 260 - 262.
[PDF]

Home page
 The Diabetes EducatorHome page
G. S. Magwood, J. Zapka, and C. Jenkins
A Review of Systematic Reviews Evaluating Diabetes Interventions: Focus on Quality of Life and Disparities
The Diabetes Educator, March 1, 2008; 34(2): 242 - 265.
[Abstract] [Full Text] [PDF]

Home page
 Int J Qual Health CareHome page
G. A. Sandoval, A. D. Brown, T. Sullivan, and E. Green
Factors that influence cancer patients' overall perceptions of the quality of care
Int. J. Qual. Health Care, August 1, 2006; 18(4): 266 - 274.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
S. C. Lemon, J. G. Zapka, B. Estabrook, and E. Benjamin
Challenges to Research in Urban Community Health Centers
Am J Public Health, April 1, 2006; 96(4): 626 - 628.
[Abstract] [Full Text] [PDF]

Home page
 Int J Qual Health CareHome page
I. Agurto, J. Sandoval, M. De La Rosa, and M. E. Guardado
Improving cervical cancer prevention in a developing country
Int. J. Qual. Health Care, April 1, 2006; 18(2): 81 - 86.
[Abstract] [Full Text] [PDF]

Home page
 American Behavioral ScientistHome page
G. L. Kreps
Communication and Racial Inequities in Health Care
American Behavioral Scientist, February 1, 2006; 49(6): 760 - 774.
[Abstract] [PDF]

Home page
 J Natl Cancer Inst MonogrHome page
E. H. Wagner, S. M. Greene, G. Hart, T. S. Field, S. Fletcher, A. M. Geiger, L. J. Herrinton, M. C. Hornbrook, C. C. Johnson, J. Mouchawar, et al.
Building a Research Consortium of Large Health Systems: The Cancer Research Network
J Natl Cancer Inst Monographs, November 1, 2005; 2005(35): 3 - 11.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Cancer Inst MonogrHome page
M. C. Hornbrook, G. Hart, J. L. Ellis, D. J. Bachman, G. Ansell, S. M. Greene, E. H. Wagner, R. Pardee, M. M. Schmidt, A. Geiger, et al.
Building a Virtual Cancer Research Organization
J Natl Cancer Inst Monographs, November 1, 2005; 2005(35): 12 - 25.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Cancer Inst MonogrHome page
J. Mouchawar, S. Taplin, L. Ichikawa, W. E. Barlow, A. M. Geiger, S. Weinmann, J. Gilbert, M. M. Manos, and M. U. Yood
Late-Stage Breast Cancer Among Women With Recent Negative Screening Mammography: Do Clinical Encounters Offer Opportunity for Earlier Detection?
J Natl Cancer Inst Monographs, November 1, 2005; 2005(35): 39 - 46.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Cancer Inst MonogrHome page
J. G. Zapka, E. Puleo, S. Taplin, L. I. Solberg, J. Mouchawar, C. Somkin, A. M. Geiger, and M. U. Yood
Breast and Cervical Cancer Screening: Clinicians' Views on Health Plan Guidelines and Implementation Efforts
J Natl Cancer Inst Monographs, November 1, 2005; 2005(35): 46 - 54.
[Abstract] [Full Text] [PDF]

Home page
 Eval Health ProfHome page
E. Puleo, J. G. Zapka, K. V. Goins, M. U. Yood, J. Mouchawar, M. Manos, C. Somkin, and S. Taplin
Recommendations for Care Related to Follow-Up of Abnormal Cancer Screening Tests: Accuracy of Patient Report
Eval Health Prof, September 1, 2005; 28(3): 310 - 327.
[Abstract] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
W. A. Leyden, M. M. Manos, A. M. Geiger, S. Weinmann, J. Mouchawar, K. Bischoff, M. U. Yood, J. Gilbert, and S. H. Taplin
Cervical Cancer in Women With Comprehensive Health Care Access: Attributable Factors in the Screening Process
J Natl Cancer Inst, May 4, 2005; 97(9): 675 - 683.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Coughlin, E. S. Breslau, T. Thompson, and V. B. Benard
Physician Recommendation for Papanicolaou Testing Among U.S. Women, 2000
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1143 - 1148.
[Abstract] [Full Text] [PDF]

Home page
 Med Care Res RevHome page
K. R. Yabroff, C. N. Klabunde, R. Myers, and M. L. Brown
Physician Recommendations for Follow-Up of Positive Fecal Occult Blood Tests
Med Care Res Rev, February 1, 2005; 62(1): 79 - 110.
[Abstract] [PDF]

Home page
 CA Cancer J ClinHome page
R. A. Smith, V. Cokkinides, and H. J. Eyre
American Cancer Society Guidelines for the Early Detection of Cancer, 2005
CA Cancer J Clin, January 1, 2005; 55(1): 31 - 44.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
W. E. Barlow, C. Chi, P. A. Carney, S. H. Taplin, C. D'Orsi, G. Cutter, R. E. Hendrick, and J. G. Elmore
Accuracy of Screening Mammography Interpretation by Characteristics of Radiologists
J Natl Cancer Inst, December 15, 2004; 96(24): 1840 - 1850.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. H. Taplin, L. Ichikawa, M. U. Yood, M. M. Manos, A. M. Geiger, S. Weinmann, J. Gilbert, J. Mouchawar, W. A. Leyden, R. Altaras, et al.
Reason for Late-Stage Breast Cancer: Absence of Screening or Detection, or Breakdown in Follow-up?
J Natl Cancer Inst, October 20, 2004; 96(20): 1518 - 1527.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
K. R. Yabroff, N. Breen, S. W. Vernon, H. I. Meissner, A. N. Freedman, and R. Ballard-Barbash
What Factors Are Associated with Diagnostic Follow-Up after Abnormal Mammograms? Findings from a U.S. National Survey
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 723 - 732.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
P. A. Ganz, M. M. Farmer, M. Belman, J. L. Malin, R. Bastani, K. L. Kahn, A. Dietrich, and J. Fielding
Improving Colorectal Cancer Screening Rates in a Managed Care Health Plan: Recruitment of Provider Organizations for a Randomized Effectiveness Trial
Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 824 - 829.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2003 by the American Association for Cancer Research.